AU6592496A - Compositions and methods for treating specific gene expression-related diseases and disorders in humans - Google Patents
Compositions and methods for treating specific gene expression-related diseases and disorders in humansInfo
- Publication number
- AU6592496A AU6592496A AU65924/96A AU6592496A AU6592496A AU 6592496 A AU6592496 A AU 6592496A AU 65924/96 A AU65924/96 A AU 65924/96A AU 6592496 A AU6592496 A AU 6592496A AU 6592496 A AU6592496 A AU 6592496A
- Authority
- AU
- Australia
- Prior art keywords
- disorders
- humans
- compositions
- methods
- gene expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000037765 diseases and disorders Diseases 0.000 title 1
- 230000014509 gene expression Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/012056 WO1998003646A1 (en) | 1996-07-22 | 1996-07-22 | Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6592496A true AU6592496A (en) | 1998-02-10 |
Family
ID=22255492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65924/96A Abandoned AU6592496A (en) | 1996-07-22 | 1996-07-22 | Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6592496A (en) |
WO (1) | WO1998003646A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7189506B1 (en) | 1999-03-03 | 2007-03-13 | Genelabs Technologies, Inc. | DNA binding compound-mediated molecular switch system |
US7345163B2 (en) * | 2002-08-28 | 2008-03-18 | Quiatech Ab | Process for separating and deprotecting oligonucleotides |
WO2008094640A2 (en) | 2007-01-30 | 2008-08-07 | Geron Corporation | Compounds having anti-adhesive effects on cancer cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
US5194428A (en) * | 1986-05-23 | 1993-03-16 | Worcester Foundation For Experimental Biology | Inhibition of influenza virus replication by oligonucleotide phosphorothioates |
EP0619736A1 (en) * | 1991-12-31 | 1994-10-19 | Worcester Foundation For Biomedical Research, Inc. | Antiparasitic oligonucleotides active against drug resistant malaria |
EP0649467B1 (en) * | 1992-07-02 | 1998-09-16 | HYBRIDON, Inc. | Self-stabilized oligonucleotides as therapeutic agents |
DE69425890D1 (en) * | 1993-06-04 | 2000-10-19 | Us Health | METHOD FOR TREATING KAPOSI SARCOMA WITH ANTISENSE OLIGONUCLEOTIDES |
JPH09505465A (en) * | 1993-09-28 | 1997-06-03 | ザ ジェネラル ホスピタル コーポレイション | Use of antisense oligonucleotides to regulate nerve proliferation and reverse β / A4 amyloid-induced morphology |
US5578716A (en) * | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
-
1996
- 1996-07-22 WO PCT/US1996/012056 patent/WO1998003646A1/en active Application Filing
- 1996-07-22 AU AU65924/96A patent/AU6592496A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998003646A1 (en) | 1998-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
AU5439996A (en) | Compositions and methods for treating pain | |
GR3036364T3 (en) | Compositions and methods for treating or preventing inflammatory diseases | |
AU4655296A (en) | Compositions and methods for treating tumor cells | |
AU1296099A (en) | Methods and compositions for treating dermatoses | |
AU6849396A (en) | Method for treatment of cancer and infectious diseases and compositions useful in same | |
EP1005345A4 (en) | Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine | |
AU2327599A (en) | Compositions and methods for treating autoimmune diseases | |
AU3725997A (en) | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | |
AU7622198A (en) | Methods of treating mental diseases, inflammation and pain | |
AU6714396A (en) | Methods and compositions for treating cell proliferative disorders | |
AU2542097A (en) | Oligonucleotide treatments and compositions for human melanoma | |
AU2804297A (en) | Method of and composition for treating disorders of the skin using vitamin k | |
AU5774699A (en) | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders | |
AU1734895A (en) | Methods and compositions for treatment of periodontal disease and repair of periodontal lesions | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
AU3768795A (en) | Method and compositions for hair treatment | |
AU5298699A (en) | Dnazymes and methods for treating hpv-related disorders | |
AU6242498A (en) | Methods for treating central and peripheral nerve pain | |
AU5333298A (en) | Compositions and methods for tumour therapy | |
AU3204899A (en) | Hair treatment composition and method | |
AU4823999A (en) | Methods and compositions for treating diseases mediated by transglutaminase activity | |
AU6252699A (en) | Composition and method for treating allergic diseases | |
AU6592496A (en) | Compositions and methods for treating specific gene expression-related diseases and disorders in humans | |
AU6281298A (en) | Use of lofexidine in the treatment of behavioral disorders |